Astrocytes & Amyloid

Astrocytes are thought to play a role in amyloid production and have been implicated in neurodegenerative diseases such as Alzheimer’s disease. Here is the latest research on the relationship between astrocytes and amyloid.

February 26, 2021
Open Access

Tetragonia tetragonioides Relieves Depressive-Like Behavior through the Restoration of Glial Loss in the Prefrontal Cortex.

Evidence-based Complementary and Alternative Medicine : ECAM
Yujin ChoiSeung-Hun Cho
February 21, 2021
Open Access

Amyloid-β1-40 differentially stimulates proliferation, activation of oxidative stress and inflammatory responses in male and female hippocampal astrocyte cultures.

Mechanisms of Ageing and Development
Matthew P LennolLaura M Frago
February 19, 2021

APOE immunotherapy reduces cerebral amyloid angiopathy and amyloid plaques while improving cerebrovascular function.

Science Translational Medicine
Monica XiongDavid M Holtzman
February 16, 2021
Open Access

Biomarkers of Neurodegeneration and Precision Therapy in Retinal Disease.

Frontiers in Pharmacology
Alessandra MiceraMarco Coassin
February 12, 2021
Open Access

Activation of RAGE leads to the release of glutamate from astrocytes and stimulates calcium signal in neurons.

Journal of Cellular Physiology
Anna KamyninaAndrey Y Abramov
February 10, 2021
Open Access

Lysine-selective molecular tweezers are cell-penetrant and concentrate in lysosomes

Zizheng LiGal Bitan
February 9, 2021
Open Access

Presenilin-Deficient Neurons and Astrocytes Display Normal Mitochondrial Phenotypes.

Frontiers in Neuroscience
Sabrina ContinoPascal Kienlen-Campard
February 9, 2021

Particulate Matter Exposure Exacerbates Amyloid-β Plaque Deposition and Gliosis in APP/PS1 Mice.

Journal of Alzheimer's Disease : JAD
Bijayani SahuColin K Combs
February 9, 2021
Open Access

Bacterial sepsis increases hippocampal fibrillar amyloid plaque load and neuroinflammation in a mouse model of Alzheimer's disease.

Neurobiology of Disease
Jacob M BasakErik S Musiek
February 6, 2021
Open Access

Implication of Nicotinamide Adenine Dinucleotide Phosphate (NADPH) Oxidase and Its Inhibitors in Alzheimer's Disease Murine Models.

Leticia Guadalupe Fragoso-MoralesMartha Cecilia Rosales-Hernández
February 1, 2021
Open Access

Changes of blood-brain-barrier function and transfer of amyloid beta in rats with collagen-induced arthritis.

Journal of Neuroinflammation
Po-Hsuan LaiChun-Jung Lin
February 2, 2021
Open Access

Deletion of LRP1 From Astrocytes Modifies Neuronal Network Activity in an in vitro Model of the Tripartite Synapse.

Frontiers in Cellular Neuroscience
Ramona RomeoAndreas Faissner
January 31, 2021
Open Access

Blood-Brain Barrier Disruption Increases Amyloid-Related Pathology in TgSwDI Mice.

International Journal of Molecular Sciences
Ihab M AbdallahAmal Kaddoumi

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.


TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

Alexander Disease

Alexander disease is a rare leukodystrophy caused by mutations in the astrocyte-specific intermediate filament protein glial fibrillary acidic protein (GFAP). Here is the latest research on this disease.

© 2021 Meta ULC. All rights reserved